Voyager Therapeutics (VYGR) Capital Expenditures (QoQ) (2015 - 2026)
Voyager Therapeutics (VYGR) Capital Expenditures (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Voyager Therapeutics | 183.84 Mn | 42.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.91% |
| Dec 31, 2025 | -845.41% |
| Sep 30, 2025 | -81.27% |
| Jun 30, 2025 | 67.93% |
| Mar 31, 2025 | 324.52% |
| Dec 31, 2024 | -39.92% |
| Sep 30, 2024 | -91.66% |
| Jun 30, 2024 | 20,520.00% |
| Mar 31, 2024 | -98.01% |
| Dec 31, 2023 | -69.17% |
| Sep 30, 2023 | 635.89% |
| Jun 30, 2023 | -189.78% |
| Mar 31, 2023 | -45.44% |
| Dec 31, 2022 | -35.43% |
| Sep 30, 2022 | 1,356.52% |
| Jun 30, 2022 | -150.44% |
| Mar 31, 2022 | 53.02% |
| Dec 31, 2021 | 122.21% |
| Sep 30, 2021 | -395.59% |
| Jun 30, 2021 | -39.47% |